SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-08-001597
Filing Date
2008-03-03
Accepted
2008-03-03 15:05:27
Documents
10
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 ATHEROGENICS, INC. g12028e10vk.htm 10-K 563522
2 EX-10.23 EMPLOYMENT AGREEMENT/RUSSELL M. MEDFORD g12028exv10w23.htm EX-10.23 81891
3 EX-10.24 EMPLOYMENT AGREEMENT/MARK P. COLONNESE g12028exv10w24.htm EX-10.24 82357
4 EX-10.25 EMPLOYMENT AGREEMENT/W. CHARLES MONTGOMERY g12028exv10w25.htm EX-10.25 82179
5 EX-10.26 EMPLOYMENT AGREEMENT/JOSEPH M. GAYNOR, JR. g12028exv10w26.htm EX-10.26 81970
6 EX-23.01 CONSENT OF ERNST & YOUNG LLP g12028exv23w01.htm EX-23.01 1500
7 EX-24.01 POWERS OF ATTORNEY g12028exv24w01.htm EX-24.01 8526
8 EX-31.1 SECTION 302 CERTIFICATION OF THE CEO g12028exv31w1.htm EX-31.1 6560
9 EX-31.2 SECTION 302 CERTIFICATION OF THE CFO g12028exv31w2.htm EX-31.2 6602
10 EX-32 SECTION 906 CERTIFICATIONS OF THE CEO AND CFO g12028exv32.htm EX-32 6609
  Complete submission text file 0000950144-08-001597.txt   922998
Mailing Address
Business Address 8995 WESTSIDE PARKWAY ALPHARETTA GA 30004 6783362500
ATHEROGENICS INC (Filer) CIK: 0001107601 (see all company filings)

IRS No.: 582108232 | State of Incorp.: GA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31261 | Film No.: 08659291
SIC: 2834 Pharmaceutical Preparations